QNCX Key Financial Ratios - Quince Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	14.52	—	-74.58%	261.79%
2026-03-31	2.92	—	-124.09%	-210.80%
2025-12-31	0.53	-0.5	-89.80%	235.14%
2025-09-30	1.12	16.54	-51.85%	-5380.45%
2025-06-30	5	—	-41.83%	-417.77%
2025-03-31	4.05	—	-56.69%	-326.73%
2024-12-31	6.05	0.48	-49.64%	-188.51%
2024-09-30	9.53	—	-42.10%	-118.54%
2024-06-30	6.15	—	-39.40%	-113.10%
2024-03-31	7.16	—	-19.01%	-40.82%
2023-12-31	8.09	—	-18.69%	-36.89%
2023-09-30	37.8	—	-32.82%	-33.71%
2023-06-30	45.36	—	-34.44%	-35.21%
2023-03-31	29.69	—	-45.30%	-46.86%
2022-12-31	30.55	—	-49.72%	-51.36%
2022-09-30	19.87	—	-63.33%	-66.51%
2022-06-30	16.7	—	-70.68%	-74.70%
2022-03-31	9.92	—	-76.21%	-83.19%
2021-12-31	7.85	—	-67.51%	-75.85%
2021-09-30	8.44	—	-59.09%	-65.66%
2021-06-30	7.33	—	-53.85%	-61.16%
2021-03-31	8.39	—	-47.42%	-52.89%
2020-12-31	8.11	—	-40.56%	-44.61%
2020-09-30	8.71	—	-33.55%	-36.53%
2020-06-30	11.07	—	-26.01%	-27.75%
2020-03-31	12.86	—	-20.97%	-22.23%
2019-12-31	11.93	—	-29.73%	-32.02%
2019-09-30	20.3	—	-21.04%	-22.05%
2019-06-30	19.02	—	-14.47%	-15.22%
2019-03-31	15.91	—	-20.94%	38.87%
2018-12-31	49.82	—	-17.12%	38.24%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	0.53	-0.5	-89.80%	235.14%
2024-12-31	6.05	0.48	-49.64%	-188.51%
2023-12-31	8.09	—	-18.69%	-36.89%
2022-12-31	30.55	—	-49.72%	-51.36%
2021-12-31	7.85	—	-67.51%	-75.85%
2020-12-31	8.11	—	-40.56%	-44.61%
2019-12-31	11.93	—	-29.73%	-32.02%
2018-12-31	49.82	—	-17.12%	38.24%